{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:12:36Z","timestamp":1788876756228,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02162-5","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:21Z","timestamp":1788871641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymoquinone as a Multi-Target Modulator of Inflammatory and Immunometabolic Signaling: Mechanisms and Therapeutic Implications"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1482-4411","authenticated-orcid":false,"given":"Abdullah Faisal","family":"Albukhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"1","key":"2162_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu, T., Liu, C. H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024). Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduction and Targeted Therapy, 9(1), 268.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"11","key":"2162_CR2","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1002\/mco2.789","volume":"5","author":"R Xu","year":"2024","unstructured":"Xu, R., He, X., Xu, J., Yu, G., & Wu, Y. (2024). Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. MedComm, 5(11), e789.","journal-title":"MedComm"},{"issue":"6","key":"2162_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018). Reactive oxygen species in metabolic and inflammatory signaling. Circulation research, 122(6), 877\u2013902.","journal-title":"Circulation research"},{"issue":"3","key":"2162_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41423-021-00780-y","volume":"19","author":"W-C Chou","year":"2022","unstructured":"Chou, W.-C., Rampanelli, E., Li, X., & Ting, J. P. (2022). Impact of intracellular innate immune receptors on immunometabolism. Cellular & molecular immunology, 19(3), 337\u2013351.","journal-title":"Cellular & molecular immunology"},{"issue":"1","key":"2162_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D., & Sun, S. C. (2017). NF-\u03baB signaling in inflammation. Signal transduction and targeted therapy, 2(1), 1\u20139.","journal-title":"Signal transduction and targeted therapy"},{"issue":"6","key":"2162_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cells13060485","volume":"13","author":"S Anilkumar","year":"2024","unstructured":"Anilkumar, S., & Wright-Jin, E. (2024). NF-\u03baB as an inducible regulator of inflammation in the central nervous system. Cells, 13(6), 485.","journal-title":"Cells"},{"issue":"1","key":"2162_CR7","doi-asserted-by":"publisher","first-page":"113614","DOI":"10.1016\/j.yexcr.2023.113614","volume":"428","author":"A Sharma","year":"2023","unstructured":"Sharma, A., Anand, S. K., Singh, N., Dwivedi, U. N., & Kakkar, P. (2023). AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis. Experimental cell research, 428(1), 113614.","journal-title":"Experimental cell research"},{"issue":"2","key":"2162_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S., & Shaw, R. J. (2018). AMPK: guardian of metabolism and mitochondrial homeostasis. Nature reviews Molecular cell biology, 19(2), 121\u2013135.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"12","key":"2162_CR9","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/antiox11122345","volume":"11","author":"V Ngo","year":"2022","unstructured":"Ngo, V., & Duennwald, M. L. (2022). Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants, 11(12), 2345.","journal-title":"Antioxidants"},{"issue":"2","key":"2162_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/biom10020320","volume":"10","author":"S Kasai","year":"2020","unstructured":"Kasai, S., Shimizu, S., Tatara, Y., Mimura, J., & Itoh, K. (2020). Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules, 10(2), 320.","journal-title":"Biomolecules"},{"issue":"3","key":"2162_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibs.2024.12.010","volume":"50","author":"JD Hayes","year":"2025","unstructured":"Hayes, J. D., Naidu, S. D., & Dinkova-Kostova, A. T. (2025). Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis. Trends in Biochemical Sciences, 50(3), 179\u2013205.","journal-title":"Trends in Biochemical Sciences"},{"key":"2162_CR12","doi-asserted-by":"publisher","first-page":"809952","DOI":"10.3389\/fcell.2021.809952","volume":"9","author":"W Gao","year":"2022","unstructured":"Gao, W., Guo, L., Yang, Y., Wang, Y., Xia, S., Gong, H., Zhang, B. K., & Yan, M. (2022). Dissecting the crosstalk between Nrf2 and NF-\u03baB response pathways in drug-induced toxicity. Frontiers in cell and developmental biology, 9, 809952.","journal-title":"Frontiers in cell and developmental biology"},{"issue":"6","key":"2162_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/biology12060776","volume":"12","author":"D Iacobazzi","year":"2023","unstructured":"Iacobazzi, D., Convertini, P., Todisco, S., Santarsiero, A., Iacobazzi, V., & Infantino, V. (2023). New insights into NF-\u03baB signaling in innate immunity: focus on immunometabolic crosstalks. Biology, 12(6), 776.","journal-title":"Biology"},{"issue":"4","key":"2162_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","volume":"146","author":"M Kracht","year":"2020","unstructured":"Kracht, M., M\u00fcller-Ladner, U., & Schmitz, M. L. (2020). Mutual regulation of metabolic processes and proinflammatory NF-\u03baB signaling. Journal of Allergy and Clinical Immunology, 146(4), 694\u2013705.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"2162_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/ijms19051355","volume":"19","author":"N Aziz","year":"2018","unstructured":"Aziz, N., Son, Y.-J., & Cho, J. Y. (2018). Thymoquinone suppresses IRF-3-mediated expression of type I interferons via suppression of TBK1. International Journal of Molecular Sciences, 19(5), 1355.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2162_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep42995","volume":"7","author":"MJ Hossen","year":"2017","unstructured":"Hossen, M. J., Yang, W. S., Kim, D., Aravinthan, A., Kim, J. H., & Cho, J. Y. (2017). Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Scientific reports, 7(1), 42995.","journal-title":"Scientific reports"},{"issue":"4","key":"2162_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/nu13041343","volume":"13","author":"B Venkataraman","year":"2021","unstructured":"Venkataraman, B., Almarzooqi, S., Raj, V., Alhassani, A. T., Alhassani, A. S., Ahmed, K. J., Subramanian, V. S., Ojha, S. K., Attoub, S., Adrian, T. E., & Subramanya, S. B. (2021). Thymoquinone, a dietary bioactive compound, exerts anti-inflammatory effects in colitis by stimulating expression of the colonic epithelial PPAR-\u03b3 transcription factor. Nutrients, 13(4), 1343.","journal-title":"Nutrients"},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.04.018","volume":"320","author":"MK Cobourne-Duval","year":"2018","unstructured":"Cobourne-Duval, M. K., Taka, E., Mendonca, P., & Soliman, K. (2018). Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NF\u03baB pathway signaling targets in LPS\/IFN\u03b3-activated BV-2 microglia cells. Journal of neuroimmunology, 320, 87\u201397.","journal-title":"Journal of neuroimmunology"},{"key":"2162_CR19","doi-asserted-by":"publisher","first-page":"615598","DOI":"10.3389\/fphar.2020.615598","volume":"11","author":"J Dong","year":"2021","unstructured":"Dong, J., Zhang, X., Wang, S., Xu, C., Gao, M., Liu, S., Li, X., Cheng, N., Han, Y., Wang, X., & Han, Y. (2021). Thymoquinone prevents dopaminergic neurodegeneration by attenuating oxidative stress via the Nrf2\/ARE pathway. Frontiers in pharmacology, 11, 615598.","journal-title":"Frontiers in pharmacology"},{"issue":"22","key":"2162_CR20","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.3390\/nu14224787","volume":"14","author":"GM Adinew","year":"2022","unstructured":"Adinew, G. M., Messeha, S. S., Taka, E., Badisa, R. B., & Soliman, K. (2022). Anticancer effects of thymoquinone through the antioxidant activity, upregulation of Nrf2, and downregulation of PD-L1 in triple-negative breast cancer cells. Nutrients, 14(22), 4787.","journal-title":"Nutrients"},{"issue":"3","key":"2162_CR21","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1002\/jcb.27739","volume":"120","author":"X Hu","year":"2019","unstructured":"Hu, X., Liang, Y., Zhao, B., & Wang, Y. (2019). Thymoquinone protects human retinal pigment epithelial cells against hydrogen peroxide induced oxidative stress and apoptosis. Journal of cellular biochemistry, 120(3), 4514\u20134522.","journal-title":"Journal of cellular biochemistry"},{"issue":"5","key":"2162_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/19396368.2019.1626933","volume":"65","author":"S Harphoush","year":"2019","unstructured":"Harphoush, S., Wu, G., Qiuli, G., Zaitoun, M., Ghanem, M., Shi, Y., & Le, G. (2019). Thymoquinone ameliorates obesity-induced metabolic dysfunction, improves reproductive efficiency exhibiting a dose-organ relationship. Systems biology in reproductive medicine, 65(5), 367\u2013382.","journal-title":"Systems biology in reproductive medicine"},{"issue":"9","key":"2162_CR23","doi-asserted-by":"publisher","first-page":"e0185374","DOI":"10.1371\/journal.pone.0185374","volume":"12","author":"S Karandrea","year":"2017","unstructured":"Karandrea, S., Yin, H., Liang, X., Slitt, A. L., & Heart, E. A. (2017). Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways. PloS one, 12(9), e0185374.","journal-title":"PloS one"},{"issue":"6","key":"2162_CR24","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1007\/s11033-023-08363-y","volume":"50","author":"E Sadeghi","year":"2023","unstructured":"Sadeghi, E., Imenshahidi, M., & Hosseinzadeh, H. (2023). Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review. Molecular biology reports, 50(6), 5439\u20135454.","journal-title":"Molecular biology reports"},{"issue":"4","key":"2162_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/ptr.6905","volume":"35","author":"M Talebi","year":"2021","unstructured":"Talebi, M., Talebi, M., Farkhondeh, T., & Samarghandian, S. (2021). Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway. Phytotherapy Research, 35(4), 1739\u20131753.","journal-title":"Phytotherapy Research"},{"key":"2162_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2017.00656","volume":"8","author":"SN Goyal","year":"2017","unstructured":"Goyal, S. N., Prajapati, C. P., Gore, P. R., Patil, C. R., Mahajan, U. B., Sharma, C., Talla, S. P., & Ojha, S. K. (2017). Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin. Frontiers in pharmacology, 8, 656.","journal-title":"Frontiers in pharmacology"},{"issue":"8","key":"2162_CR27","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jsps.2019.09.008","volume":"27","author":"A Ahmad","year":"2019","unstructured":"Ahmad, A., Mishra, R. K., Vyawahare, A., Kumar, A., Rehman, M. U., Qamar, W., Khan, A. Q., & Khan, R. (2019). Thymoquinone (2-Isopropyl-5-methyl-1, 4-benzoquinone) as a chemopreventive\/anticancer agent: Chemistry and biological effects. Saudi Pharmaceutical Journal, 27(8), 1113\u20131126.","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"4","key":"2162_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jsps.2020.01.022","volume":"28","author":"A Ahmad","year":"2020","unstructured":"Ahmad, A., Alqahtani, S., Jan, B. L., Raish, M., Rabba, A. K., & Alkharfy, K. M. (2020). Gender effect on the pharmacokinetics of thymoquinone: preclinical investigation and in silico modeling in male and female rats. Saudi Pharmaceutical Journal, 28(4), 403\u2013408.","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"14","key":"2162_CR29","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.3390\/molecules28145435","volume":"28","author":"A Shoaib","year":"2023","unstructured":"Shoaib, A., Javed, S., Wahab, S., Azmi, L., Tabish, M., Sultan, M. H., Abdelsalam, K., Alqahtani, S. S., & Ahmad, M. F. (2023). Cellular, molecular, pharmacological, and nano-formulation aspects of thymoquinone\u2014a potent natural antiviral agent. Molecules, 28(14), 5435.","journal-title":"Molecules"},{"issue":"1","key":"2162_CR30","doi-asserted-by":"publisher","first-page":"2337423","DOI":"10.1080\/10717544.2024.2337423","volume":"31","author":"S Halder","year":"2024","unstructured":"Halder, S., Afrose, S., Shill, M. C., Sharmin, N., Mollick, P. P., Shuma, M. L., Muhit, M. A., & Rahman, S. (2024). Self-micellizing solid dispersion of thymoquinone with enhanced biopharmaceutical and nephroprotective effects. Drug Delivery, 31(1), 2337423.","journal-title":"Drug Delivery"},{"issue":"1","key":"2162_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40097-021-00398-6","volume":"12","author":"N Barrie","year":"2022","unstructured":"Barrie, N., Manolios, N., Stuart, J., Chew, T., Arnold, J., Sadsad, R., De Campo, L., Knott, R. B., White, J., Booth, D., Ali, M., & Moghaddam, M. J. (2022). Effect of thymoquinone-loaded lipid\u2013polymer nanoparticles as an oral delivery system on anticancer efficiency of doxorubicin. Journal of nanostructure in chemistry, 12(1), 33\u201344.","journal-title":"Journal of nanostructure in chemistry"},{"key":"2162_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jddst.2018.08.019","volume":"47","author":"M Mohammadabadi","year":"2018","unstructured":"Mohammadabadi, M., & Mozafari, M. (2018). Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form. Journal of drug delivery science and technology, 47, 445\u2013453.","journal-title":"Journal of drug delivery science and technology"},{"issue":"3","key":"2162_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1208\/s12249-015-0391-0","volume":"17","author":"M Elmowafy","year":"2016","unstructured":"Elmowafy, M., Samy, A., Raslan, M. A., Salama, A., Said, R. A., Abdelaziz, A. E., El-Eraky, W., El Awdan, S., & Viitala, T. (2016). Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation. Aaps Pharmscitech, 17(3), 663\u2013672.","journal-title":"Aaps Pharmscitech"},{"key":"2162_CR34","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.2147\/IJN.S262395","volume":"15","author":"FH Zakarial Ansar","year":"2020","unstructured":"Zakarial Ansar, F. H., Latifah, S. Y., Wan Kamal, W., Khong, K. C., Ng, Y., Foong, J. N., Gopalsamy, B., Ng, W. K., How, C. W., Ong, Y. S., Abdullah, R., & Aziz, M. Y. (2020). Pharmacokinetics and biodistribution of thymoquinone-loaded nanostructured lipid carrier after oral and intravenous administration into rats. International journal of nanomedicine, 15, 7703\u20137717.","journal-title":"International journal of nanomedicine"},{"issue":"10","key":"2162_CR35","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/medicina61101835","volume":"61","author":"S Karao\u011flano\u011flu","year":"2025","unstructured":"Karao\u011flano\u011flu, S., & G\u00fclbay, G. (2025). Effects of thymoquinone on cell proliferation, oxidative damage, and toll-like signaling pathway genes in H1650 lung adenocarcinoma cell line. Medicina, 61(10), 1835.","journal-title":"Medicina"},{"issue":"1","key":"2162_CR36","doi-asserted-by":"publisher","first-page":"e0318185","DOI":"10.1371\/journal.pone.0318185","volume":"20","author":"R Pandey","year":"2025","unstructured":"Pandey, R., Natarajan, P., Reddy, U. K., Du, W., Sirbu, C., Sissoko, M., & Hankins, G. R. (2025). Deciphering the dose-dependent effects of thymoquinone on cellular proliferation and transcriptomic changes in A172 glioblastoma cells. Plos one, 20(1), e0318185.","journal-title":"Plos one"},{"issue":"9","key":"2162_CR37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1248\/bpb.b22-00199","volume":"45","author":"M Mizuno","year":"2022","unstructured":"Mizuno, M., & Fukuhara, K. (2022). Antioxidant and prooxidant effects of thymoquinone and its hydroquinone metabolite. Biological and Pharmaceutical Bulletin, 45(9), 1389\u20131393.","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"3","key":"2162_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/antiox12030607","volume":"12","author":"R Sakib","year":"2023","unstructured":"Sakib, R., Caruso, F., Aktar, S., Belli, S., Kaur, S., Hernandez, M., & Rossi, M. (2023). Antioxidant properties of thymoquinone, thymohydroquinone and black cumin (Nigella sativa L.) seed oil: scavenging of superoxide radical studied using cyclic voltammetry, DFT and single crystal X-ray diffraction. Antioxidants, 12(3), 607.","journal-title":"Antioxidants"},{"issue":"6","key":"2162_CR39","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s11095-010-0145-3","volume":"27","author":"S Banerjee","year":"2010","unstructured":"Banerjee, S., Azmi, A. S., Padhye, S., Singh, M. W., Baruah, J. B., Philip, P. A., Sarkar, F. H., & Mohammad, R. M. (2010). Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer. Pharmaceutical research, 27(6), 1146\u20131158.","journal-title":"Pharmaceutical research"},{"issue":"1","key":"2162_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","volume":"55","author":"NM Chapman","year":"2022","unstructured":"Chapman, N. M., & Chi, H. (2022). Metabolic adaptation of lymphocytes in immunity and disease. Immunity, 55(1), 14\u201330.","journal-title":"Immunity"},{"issue":"5","key":"2162_CR41","first-page":"e1486","volume":"12","author":"MD Kornberg","year":"2020","unstructured":"Kornberg, M. D. (2020). The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 12(5), e1486.","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"issue":"11","key":"2162_CR42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/bies.201300084","volume":"35","author":"EM Palsson\u2010McDermott","year":"2013","unstructured":"Palsson\u2010McDermott, E. M., & O\u2019neill, L. A. (2013). The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays, 35(11), 965\u2013973.","journal-title":"Bioessays"},{"key":"2162_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.redox.2017.01.023","volume":"12","author":"HR Griffiths","year":"2017","unstructured":"Griffiths, H. R., Gao, D., & Pararasa, C. (2017). Redox regulation in metabolic programming and inflammation. Redox biology, 12, 50\u201357.","journal-title":"Redox biology"},{"key":"2162_CR44","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3389\/fimmu.2018.01464","volume":"9","author":"K Fan","year":"2018","unstructured":"Fan, K., Lin, L., Ai, Q., Wan, J., Dai, J., Liu, G., Tang, L., Yang, Y., Ge, P., Jiang, R., & Zhang, L. (2018). Lipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy. Frontiers in immunology, 9, 1464.","journal-title":"Frontiers in immunology"},{"issue":"7","key":"2162_CR45","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.immuni.2025.06.010","volume":"58","author":"CH Patel","year":"2025","unstructured":"Patel, C. H., & Powell, J. D. (2025). More TOR: The expanding role of mTOR in regulating immune responses. Immunity, 58(7), 1629\u20131645.","journal-title":"Immunity"},{"issue":"568","key":"2162_CR46","doi-asserted-by":"publisher","first-page":"eaar5926","DOI":"10.1126\/scisignal.aar5926","volume":"12","author":"M Herb","year":"2019","unstructured":"Herb, M., Gluschko, A., Wiegmann, K., Farid, A., Wolf, A., Uterm\u00f6hlen, O., Krut, O., Kr\u00f6nke, M., & Schramm, M. (2019). Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO. Science signaling, 12(568), eaar5926.","journal-title":"Science signaling"},{"key":"2162_CR47","doi-asserted-by":"publisher","first-page":"967193","DOI":"10.3389\/fimmu.2022.967193","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L., & He, C. (2022). Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Frontiers in immunology, 13, 967193.","journal-title":"Frontiers in immunology"},{"issue":"1","key":"2162_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12979-025-00522-y","volume":"22","author":"M Ahmed","year":"2025","unstructured":"Ahmed, M. (2025). Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol. Immunity & Ageing, 22(1), 28.","journal-title":"Immunity & Ageing"},{"issue":"6","key":"2162_CR49","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/biomedicines10061250","volume":"10","author":"D Liu","year":"2022","unstructured":"Liu, D., Zhong, Z., & Karin, M. (2022). NF-\u03baB: A double-edged sword controlling inflammation. Biomedicines, 10(6), 1250.","journal-title":"Biomedicines"},{"issue":"1","key":"2162_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020). Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal transduction and targeted therapy, 5(1), 209.","journal-title":"Signal transduction and targeted therapy"},{"issue":"1","key":"2162_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan, M. J., & Liu, Z.-g (2011). Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell research, 21(1), 103\u2013115.","journal-title":"Cell research"},{"key":"2162_CR52","doi-asserted-by":"publisher","first-page":"1040857","DOI":"10.3389\/fphar.2022.1040857","volume":"13","author":"SA Algaidi","year":"2022","unstructured":"Algaidi, S. A., Faddladdeen, K. A., Alrefaei, G. I., Qahl, S. H., Albadawi, E. A., ALmohaimeed, H. M., & Ayuob, N. N. (2022). Thymoquinone protects the testes of hypothyroid rats by suppressing pro-inflammatory cytokines and oxidative stress and promoting SIRT1 testicular expression. Frontiers in Pharmacology, 13, 1040857.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"2162_CR53","doi-asserted-by":"publisher","first-page":"24040","DOI":"10.1016\/j.heliyon.2024.e24040","volume":"10","author":"F Mohammadi","year":"2024","unstructured":"Mohammadi, F., Rahimi, K., Ahmadi, A., Hooshmandi, Z., Amini, S., & Mohammadi, A. (2024). Anti-inflammatory effects of Mentha pulegium L. extract on human peripheral blood mononuclear cells are mediated by TLR-4 and NF-\u03baB suppression. Heliyon, 10(1), 24040.","journal-title":"Heliyon"},{"issue":"6","key":"2162_CR54","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s10753-015-0206-1","volume":"38","author":"D Wang","year":"2015","unstructured":"Wang, D., Qiao, J., Zhao, X., Chen, T., & Guan, D. (2015). Thymoquinone inhibits IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes by suppressing NF-\u03baB and MAPKs signaling pathway. Inflammation, 38(6), 2235\u20132241.","journal-title":"Inflammation"},{"issue":"4","key":"2162_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg, G. R., & Hardie, D. G. (2023). New insights into activation and function of the AMPK. Nature reviews Molecular cell biology, 24(4), 255\u2013272.","journal-title":"Nature reviews Molecular cell biology"},{"key":"2162_CR56","doi-asserted-by":"crossref","unstructured":"Sun (\u5b59\u674e\u54f2), L., Yang (\u6768\u6653\u5cf0) X., Yuan (\u8881\u7956\u8d3b) Z., Wang (\u738b\u8679) H., Metabolic reprogramming in immune response and tissue inflammation. Arteriosclerosis, thrombosis, and vascular biology, 2020. 40(9): p. 1990-2001.","DOI":"10.1161\/ATVBAHA.120.314037"},{"issue":"3","key":"2162_CR57","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","volume":"17","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche, J., Baardman, J., Otto, N. A., van der Velden, S., Neele, A. E., van den Berg, S. M., Luque-Martin, R., Chen, H. J., Boshuizen, M. C., Ahmed, M., Hoeksema, M. A., de Vos, A. F., & de Winther, M. P. (2016). Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell reports, 17(3), 684\u2013696.","journal-title":"Cell reports"},{"key":"2162_CR58","doi-asserted-by":"publisher","first-page":"1166214","DOI":"10.3389\/fimmu.2023.1166214","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S., Liao, Z., & Xu, P. (2023). Mitochondrial control of innate immune responses. Frontiers in Immunology, 14, 1166214.","journal-title":"Frontiers in Immunology"},{"key":"2162_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/JIR.S232009","volume":"13","author":"Z Geto","year":"2020","unstructured":"Geto, Z., Molla, M. D., Challa, F., Belay, Y., & Getahun, T. (2020). Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases. Journal of inflammation research, 13, 97\u2013107.","journal-title":"Journal of inflammation research"},{"issue":"1","key":"2162_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03847-x","volume":"14","author":"K Ramineedu","year":"2024","unstructured":"Ramineedu, K., Sankaran, K. R., Mallepogu, V., Rendedula, D. P., Gunturu, R., Gandham, S., Md, S. I., & Meriga, B. (2024). Thymoquinone mitigates obesity and diabetic parameters through regulation of major adipokines, key lipid metabolizing enzymes and AMPK\/p-AMPK in diet-induced obese rats. 3 Biotech, 14(1), 16.","journal-title":"3 Biotech"},{"key":"2162_CR61","doi-asserted-by":"crossref","unstructured":"Wang, D. and H. J. Eisen, Mechanistic target of rapamycin (mTOR) inhibitors, in Pharmacology of Immunosuppression. 2022, Springer. p. 53-72.","DOI":"10.1007\/164_2021_553"},{"issue":"7","key":"2162_CR62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen, A., Hyttinen, J. M., & Kaarniranta, K. (2011). AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. Journal of molecular medicine, 89(7), 667\u2013676.","journal-title":"Journal of molecular medicine"},{"issue":"2","key":"2162_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/dna.2014.2630","volume":"34","author":"B-P Huang","year":"2015","unstructured":"Huang, B.-P., Lin, C. H., Chen, H. M., Lin, J. T., Cheng, Y. F., & Kao, S. H. (2015). AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K\/p38 MAPK and NF-\u03baB signaling in murine macrophages. DNA and cell biology, 34(2), 133\u2013141.","journal-title":"DNA and cell biology"},{"issue":"6","key":"2162_CR64","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1134\/S0006350916060154","volume":"61","author":"GG Martinovich","year":"2016","unstructured":"Martinovich, G. G., Martinovich, I. V., Vcherashniaya, A. V., Shadyro, O. I., & Cherenkevich, S. N. (2016). Thymoquinone, a biologically active component of Nigella sativa, induces mitochondrial production of reactive oxygen species and programmed death of tumor cells. Biophysics, 61(6), 963\u2013970.","journal-title":"Biophysics"},{"key":"2162_CR65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cbi.2018.06.013","volume":"292","author":"M Zhang","year":"2018","unstructured":"Zhang, M., Du, H., Huang, Z., Zhang, P., Yue, Y., Wang, W., Liu, W., Zeng, J., Ma, J., Chen, G., Wang, X., & Fan, J. (2018). Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chemico-biological interactions, 292, 65\u201375.","journal-title":"Chemico-biological interactions"},{"issue":"23","key":"2162_CR66","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.3390\/ijms232314669","volume":"23","author":"RJ Abdualmjid","year":"2022","unstructured":"Abdualmjid, R. J., & Sergi, C. M. (2022). Mitochondrial dysfunction and induction of apoptosis in hepatocellular carcinoma and cholangiocarcinoma cell lines by thymoquinone. International Journal of Molecular Sciences, 23(23), 14669.","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"2162_CR67","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies, H., & Jones, D. P. (2020). Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature reviews Molecular cell biology, 21(7), 363\u2013383.","journal-title":"Nature reviews Molecular cell biology"},{"key":"2162_CR68","doi-asserted-by":"publisher","first-page":"102795","DOI":"10.1016\/j.redox.2023.102795","volume":"64","author":"K Bode","year":"2023","unstructured":"Bode, K., Hauri-Hohl, M., Jaquet, V., & Weyd, H. (2023). Unlocking the power of NOX2: A comprehensive review on its role in immune regulation. Redox biology, 64, 102795.","journal-title":"Redox biology"},{"key":"2162_CR69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","volume":"88","author":"LE Tebay","year":"2015","unstructured":"Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015). Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radical Biology and Medicine, 88, 108\u2013146.","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"2162_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1183\/09031936.06.00053805","volume":"28","author":"I Rahman","year":"2006","unstructured":"Rahman, I., & Adcock, I. (2006). Oxidative stress and redox regulation of lung inflammation in COPD. European respiratory journal, 28(1), 219\u2013242.","journal-title":"European respiratory journal"},{"issue":"22","key":"2162_CR71","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020). An overview of Nrf2 signaling pathway and its role in inflammation. Molecules, 25(22), 5474.","journal-title":"Molecules"},{"key":"2162_CR72","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.tiv.2025.106165","volume":"111","author":"UK Kolac","year":"2025","unstructured":"Kolac, U. K., Goker Bagca, B., Donmez Yalcin, G., Taskiran, M. I., & Kara, S. S. (2025). Thymoquinone attenuates poly (I: C)-induced cellular stress via PKR\/ATF4\/CHOP signaling and autophagy modulation in human alveolar epithelial cells. Toxicology in Vitro, 111, 106165.","journal-title":"Toxicology in Vitro"},{"issue":"12","key":"2162_CR73","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1007\/s11064-016-2047-1","volume":"41","author":"MK Cobourne-Duval","year":"2016","unstructured":"Cobourne-Duval, M. K., Taka, E., Mendonca, P., Bauer, D., & Soliman, K. F. (2016). The antioxidant effects of thymoquinone in activated BV-2 murine microglial cells. Neurochemical research, 41(12), 3227\u20133238.","journal-title":"Neurochemical research"},{"issue":"7","key":"2162_CR74","doi-asserted-by":"publisher","first-page":"e07561","DOI":"10.1016\/j.heliyon.2021.e07561","volume":"7","author":"AA Khalifa","year":"2021","unstructured":"Khalifa, A. A., Rashad, R. M., & El-Hadidy, W. F. (2021). Thymoquinone protects against cardiac mitochondrial DNA loss, oxidative stress, inflammation and apoptosis in isoproterenol-induced myocardial infarction in rats. Heliyon, 7(7), e07561.","journal-title":"Heliyon"},{"issue":"9","key":"2162_CR75","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., & Franzoso, G. (2022). NF-\u03baB: blending metabolism, immunity, and inflammation. Trends in immunology, 43(9), 757\u2013775.","journal-title":"Trends in immunology"},{"issue":"16","key":"2162_CR76","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/cells12162048","volume":"12","author":"I Fiorilla","year":"2023","unstructured":"Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023). Chronic inflammation, oxidative stress and metabolic plasticity: three players driving the pro-tumorigenic microenvironment in malignant mesothelioma. Cells, 12(16), 2048.","journal-title":"Cells"},{"issue":"5","key":"2162_CR77","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro, C., & Firestein, B. L. (2021). Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells, 10(5), 1056.","journal-title":"Cells"},{"issue":"1","key":"2162_CR78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-013-1930-1","volume":"389","author":"AE Ashour","year":"2014","unstructured":"Ashour, A. E., Abd-Allah, A. R., Korashy, H. M., Attia, S. M., Alzahrani, A. Z., Saquib, Q., Bakheet, S. A., Abdel-Hamied, H. E., Jamal, S., & Rishi, A. K. (2014). Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Molecular and cellular biochemistry, 389(1), 85\u201398.","journal-title":"Molecular and cellular biochemistry"},{"issue":"1","key":"2162_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-016-2703-4","volume":"416","author":"AE Ashour","year":"2016","unstructured":"Ashour, A. E., Ahmed, A. F., Kumar, A., Zoheir, K. M., Aboul-Soud, M. A., Ahmad, S. F., Attia, S. M., Abd-Allah, A. R., Cheryan, V. T., & Rishi, A. K. (2016). Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-\u03baB signaling and IL-8 expression. Molecular and cellular biochemistry, 416(1), 141\u2013155.","journal-title":"Molecular and cellular biochemistry"},{"issue":"4","key":"2162_CR80","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/09553002.2025.2449953","volume":"101","author":"M Gurbilek","year":"2025","unstructured":"Gurbilek, M., Deniz, C. D., Eroglu Gunes, C., Kurar, E., Reisli, I., Kursunel, M. A., Topcu, C., & Koc, M. (2025). Anticancer activity of thymoquinone in non-small cell lung cancer and possible involvement of PPAR-\u03b3 pathway. International Journal of Radiation Biology, 101(4), 370\u2013381.","journal-title":"International Journal of Radiation Biology"},{"key":"2162_CR81","doi-asserted-by":"publisher","first-page":"116628","DOI":"10.1016\/j.lfs.2019.116628","volume":"232","author":"M Fatfat","year":"2019","unstructured":"Fatfat, M., Fakhoury, I., Habli, Z., Mismar, R., & Gali-Muhtasib, H. (2019). Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms. Life sciences, 232, 116628.","journal-title":"Life sciences"},{"issue":"3","key":"2162_CR82","doi-asserted-by":"publisher","first-page":"e14492","DOI":"10.1111\/cbdd.14492","volume":"103","author":"MK Fath","year":"2024","unstructured":"Fath, M. K., Nasiri, K., Ghasemzadeh, S., Nejati, S. T., Ghafari, N., Masouleh, S. S., Dadgar, E., Kazemi, K. S., & Esfahaniani, M. (2024). Thymoquinone potentiates anti\u2010cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress. Chemical biology & drug design, 103(3), e14492.","journal-title":"Chemical biology & drug design"},{"issue":"6","key":"2162_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","volume":"27","author":"L Catrysse","year":"2017","unstructured":"Catrysse, L., & Van Loo, G. (2017). Inflammation and the metabolic syndrome: the tissue-specific functions of NF-\u03baB. Trends in cell biology, 27(6), 417\u2013429.","journal-title":"Trends in cell biology"},{"issue":"3","key":"2162_CR84","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ptr.7662","volume":"37","author":"D Zhang","year":"2023","unstructured":"Zhang, D., Zhang, Y., Wang, Z., & Lei, L. (2023). Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR\/ULK1\u2010dependent pathway in nonalcoholic fatty liver disease. Phytotherapy Research, 37(3), 781\u2013797.","journal-title":"Phytotherapy Research"},{"issue":"1","key":"2162_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62780-y","volume":"14","author":"MH Hafez","year":"2024","unstructured":"Hafez, M. H., Ez Elarab, S. M., Tohamy, H. G., & El-Far, A. H. (2024). Thymoquinone attenuates diabetes-induced hepatic damage in rat via regulation of oxidative\/nitrosative stress, apoptosis, and inflammatory cascade with molecular docking approach. Scientific reports, 14(1), 13016.","journal-title":"Scientific reports"},{"issue":"1-2","key":"2162_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000480018","volume":"101","author":"AG El-Shemi","year":"2017","unstructured":"El-Shemi, A. G., Kensara, O. A., Alsaegh, A., & Mukhtar, M. H. (2017). Pharmacotherapy with thymoquinone improved pancreatic \u03b2-cell integrity and functional activity, enhanced islets revascularization, and alleviated metabolic and hepato-renal disturbances in streptozotocin-induced diabetes in rats. Pharmacology, 101(1-2), 9\u201321.","journal-title":"Pharmacology"},{"issue":"11","key":"2162_CR87","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu, D. M., Niculescu, A. G., Lungu, I. I., Radu, C. I., Vlad\u00e2cenco, O., Roza, E., Cost\u0103chescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022). An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. International journal of molecular sciences, 23(11), 5938.","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"2162_CR88","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/biomedicines13020327","volume":"13","author":"K Meng","year":"2025","unstructured":"Meng, K., Jia, H., Hou, X., Zhu, Z., Lu, Y., Feng, Y., Feng, J., Xia, Y., Tan, R., Cui, F., & Yuan, J. (2025). Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies. Biomedicines, 13(2), 327.","journal-title":"Biomedicines"},{"issue":"7","key":"2162_CR89","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/14728222.2021.1952986","volume":"25","author":"N Amin","year":"2021","unstructured":"Amin, N., Du, X., Chen, S., Ren, Q., Hussien, A. B., Botchway, B., Hu, Z., & Fang, M. (2021). Therapeutic impact of thymoquninone to alleviate ischemic brain injury via Nrf2\/HO-1 pathway. Expert Opinion on Therapeutic Targets, 25(7), 597\u2013612.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"2","key":"2162_CR90","doi-asserted-by":"publisher","first-page":"155932581876145","DOI":"10.1177\/1559325818761455","volume":"16","author":"T Farkhondeh","year":"2018","unstructured":"Farkhondeh, T., Samarghandian, S., Shahri, A., & Samini, F. (2018). The neuroprotective effects of thymoquinone: a review. Dose-response, 16(2), 1559325818761455.","journal-title":"Dose-response"},{"issue":"3","key":"2162_CR91","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells10030659","volume":"10","author":"HYK Yip","year":"2021","unstructured":"Yip, H. Y. K., & Papa, A. (2021). Signaling pathways in cancer: therapeutic targets, combinatorial treatments, and new developments. Cells, 10(3), 659.","journal-title":"Cells"},{"issue":"18","key":"2162_CR92","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/polym14183705","volume":"14","author":"SS Imam","year":"2022","unstructured":"Imam, S. S., Gilani, S. J., Bin Jumah, M. N., Rizwanullah, M., Zafar, A., Ahmed, M. M., & Alshehri, S. (2022). Harnessing lipid polymer hybrid nanoparticles for enhanced oral bioavailability of thymoquinone: in vitro and in vivo assessments. Polymers, 14(18), 3705.","journal-title":"Polymers"},{"issue":"1","key":"2162_CR93","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/10717544.2021.1927245","volume":"28","author":"I Rahat","year":"2021","unstructured":"Rahat, I., Imam, S. S., Rizwanullah, M., Alshehri, S., Asif, M., Kala, C., & Taleuzzaman, M. (2021). Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments. Drug Delivery, 28(1), 973\u2013984.","journal-title":"Drug Delivery"},{"issue":"1","key":"2162_CR94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s13346-022-01193-8","volume":"13","author":"C Rathore","year":"2023","unstructured":"Rathore, C., Hemrajani, C., Sharma, A. K., Gupta, P. K., Jha, N. K., Aljabali, A., Gupta, G., Singh, S. K., Yang, J. C., Dwivedi, R. P., Dua, K., Chellappan, D. K., Negi, P., & Tambuwala, M. M. (2023). Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies. Drug Delivery and Translational Research, 13(1), 292\u2013307.","journal-title":"Drug Delivery and Translational Research"},{"key":"2162_CR95","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.2147\/IJN.S114205","volume":"11","author":"YS Ong","year":"2016","unstructured":"Ong, Y. S., Saiful Yazan, L., Ng, W. K., Noordin, M. M., Sapuan, S., Foo, J. B., & Tor, Y. S. (2016). Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB\/c mice. International journal of nanomedicine, 11, 5905\u20135915.","journal-title":"International journal of nanomedicine"},{"key":"2162_CR96","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejpb.2019.12.016","volume":"148","author":"S Zafar","year":"2020","unstructured":"Zafar, S., Akhter, S., Garg, N., Selvapandiyan, A., Kumar Jain, G., & Ahmad, F. J. (2020). Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics, 148, 10\u201326.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"12","key":"2162_CR97","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1111\/cas.13808","volume":"109","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Fan, Y., Huang, S., Wang, G., Han, R., Lei, F., Luo, A., Jing, X., Zhao, L., Gu, S., & Zhao, X. (2018). Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK\/mTOR signaling pathway. Cancer science, 109(12), 3865\u20133873.","journal-title":"Cancer science"},{"key":"2162_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intimp.2017.04.018","volume":"48","author":"R Velagapudi","year":"2017","unstructured":"Velagapudi, R., Kumar, A., Bhatia, H. S., El-Bakoush, A., Lepiarz, I., Fiebich, B. L., & Olajide, O. A. (2017). Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2\/ARE signalling. International Immunopharmacology, 48, 17\u201329.","journal-title":"International Immunopharmacology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02162-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:03:08Z","timestamp":1788876188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":98,"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02162-5","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study, as it is a narrative review based exclusively on previously published literature and does not involve human participants or animal experimentation.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}